Cyclacel Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CYCC for the last quarter is 31.00 k USD, and it's 93.75% higher compared to the previous quarter. The net income of Q4 23 is -5.27 M USD.